Ekberg H |
Calcineurin inhibitor sparing in renal transplantation. |
2008 |
Transplantation |
pmid:18813097
|
Fischer L et al. |
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. |
2015 |
Transplantation |
pmid:26151607
|
Hernández D et al. |
Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression. |
2007 |
Transplantation |
pmid:17893603
|
Singh N et al. |
Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. |
2000 |
Transplantation |
pmid:10708096
|
Ouyang J et al. |
Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections. |
2005 |
Transplantation |
pmid:15912108
|
Boyer O et al. |
Improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil. |
2005 |
Transplantation |
pmid:15912111
|
Gonwa T et al. |
Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. |
2003 |
Transplantation |
pmid:12717205
|
Abbott KC et al. |
New-onset gout after kidney transplantation: incidence, risk factors and implications. |
2005 |
Transplantation |
pmid:16340779
|
Villanueva G and Baldwin D |
Rosiglitazone therapy of posttransplant diabetes mellitus. |
2005 |
Transplantation |
pmid:16340782
|
Han DH et al. |
Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene. |
2010 |
Transplantation |
pmid:20562737
|
Kim CD et al. |
Metabonomic analysis of serum metabolites in kidney transplant recipients with cyclosporine A- or tacrolimus-based immunosuppression. |
2010 |
Transplantation |
pmid:20842074
|
Shield CF et al. |
Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group. |
1997 |
Transplantation |
pmid:9422413
|
Demetris AJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. |
1992 |
Transplantation |
pmid:1374944
|
Al-Uzri A et al. |
Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). |
2001 |
Transplantation |
pmid:11579294
|
Manitpisitkul W et al. |
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. |
2009 |
Transplantation |
pmid:19584685
|
Dominguez J et al. |
Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience. |
2000 |
Transplantation |
pmid:11063349
|
Esquivel CO et al. |
Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients. |
1996 |
Transplantation |
pmid:8607198
|
Nogueira JM et al. |
A comparison of recipient renal outcomes with laparoscopic versus open live donor nephrectomy. |
1999 |
Transplantation |
pmid:10096529
|
Hoogduijn MJ et al. |
Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin. |
2008 |
Transplantation |
pmid:19005411
|
Heidt S et al. |
Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin. |
2008 |
Transplantation |
pmid:19005412
|
Bellon H et al. |
The Effect of Immunosuppression on Airway Integrity. |
2017 |
Transplantation |
pmid:28471870
|
Tzakis AG et al. |
Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. |
2004 |
Transplantation |
pmid:15114087
|
Bechstein WO et al. |
Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial. |
2004 |
Transplantation |
pmid:15114089
|
Gregory CR et al. |
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. |
1995 |
Transplantation |
pmid:7533955
|
Egawa H et al. |
Isolated alkaline phosphatemia following pediatric liver transplantation in the FK506 ERA. |
1995 |
Transplantation |
pmid:7533958
|
Gill JS et al. |
Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection. |
2010 |
Transplantation |
pmid:20098280
|
Wallia A et al. |
Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. |
2010 |
Transplantation |
pmid:20098286
|
Vivarelli M et al. |
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. |
2010 |
Transplantation |
pmid:20098287
|
Pascual J et al. |
Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. |
2009 |
Transplantation |
pmid:19136902
|
Qi S et al. |
Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey. |
2000 |
Transplantation |
pmid:10798741
|
McDiarmid SV et al. |
Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients. |
1993 |
Transplantation |
pmid:7685933
|
Gullestad L et al. |
Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial. |
2010 |
Transplantation |
pmid:20061999
|
Pascual M et al. |
Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. |
1998 |
Transplantation |
pmid:9869086
|
Strumph P et al. |
The effect of FK506 on glycemic response as assessed by the hyperglycemic clamp technique. |
1995 |
Transplantation |
pmid:7542815
|
Kasahara M et al. |
Role of HLA compatibility in pediatric living-related liver transplantation. |
2002 |
Transplantation |
pmid:12438966
|
Hudnall SD |
Cardiac hypertrophy postliver transplantation: a role for FK506 and cyclosporine A? |
2002 |
Transplantation |
pmid:12369583
|
Opelz G and Döhler B |
Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant. |
2008 |
Transplantation |
pmid:18698238
|
Pape E et al. |
Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations. |
2015 |
Transplantation |
pmid:26308424
|
Arai K et al. |
Limb allografts in rats immunosuppressed with FK506. I. Reversal of rejection and indefinite survival. |
1989 |
Transplantation |
pmid:2479130
|
Kawano K et al. |
A protective effect of FK506 in ischemically injured rat livers. |
1991 |
Transplantation |
pmid:1713362
|
Chan L et al. |
Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness. |
2008 |
Transplantation |
pmid:18360262
|
Armitage JM et al. |
Preliminary experience with FK506 in thoracic transplantation. |
1991 |
Transplantation |
pmid:1713363
|
de Jonge H et al. |
Reduced C0 concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation. |
2010 |
Transplantation |
pmid:20592652
|
Higgins RM et al. |
Conversion from tacrolimus to cyclosporin in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison. |
2000 |
Transplantation |
pmid:10919600
|
Puig I Marà JM et al. |
Reflex sympathetic dystrophy syndrome of the lower limbs in a renal transplant patient treated with tacrolimus. |
2000 |
Transplantation |
pmid:10919604
|
Zieliński A et al. |
Simultaneous pancreas-kidney transplant from living related donor: a single-center experience. |
2003 |
Transplantation |
pmid:12923442
|
Erickson LM et al. |
Microarray-based gene expression profiles of allograft rejection and immunosuppression in the rat heart transplantation model. |
2003 |
Transplantation |
pmid:12923448
|
Wong W et al. |
2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors? |
2005 |
Transplantation |
pmid:16082321
|
Krämer BK et al. |
Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial. |
2012 |
Transplantation |
pmid:22858806
|
Ryu S and Yasunami Y |
The necessity of differential immunosuppression for prevention of immune rejection by FK506 in rat islet allografts transplanted into the liver or beneath the kidney capsule. |
1991 |
Transplantation |
pmid:1718064
|